Saitama, Japan

Junji Kamon



Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • Tokyo, JP (2010)
  • Saitama, JP (2009 - 2012)
  • Minami-saitama-gun, JP (2013 - 2017)

Company Filing History:


Years Active: 2009-2017

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: **Junji Kamon: A Pioneering Innovator in JAK Inhibitors**

Introduction

Junji Kamon, an esteemed inventor based in Saitama, Japan, has made significant contributions to the field of medicinal chemistry. With a remarkable portfolio of seven patents, he has focused on developing novel compounds that show promise in treating various medical conditions.

Latest Patents

Among his latest innovations are two pivotal patents:

1. **Substituted pyrrolo[3',2':5,6]pyrido[4,3-d]pyrimidines and JAK inhibitors comprising the same**. This patent involves the development of innovative tricyclic pyrimidine and pyridine compounds specifically designed to exhibit JAK inhibitory activities. The structure is defined by a compound represented by formula (I), where the components are elaborately outlined in the specification.

2. **Substituted pyrrolo[2,3-h][1,6]naphthyridines and compositions thereof as JAK inhibitors**. Similar to the first, this patent offers novel tricyclic compounds that possess JAK inhibitory capabilities. The compounds, represented by formula (I), are defined through a detailed specification, highlighting their potential therapeutic applications.

Career Highlights

Junji Kamon has garnered invaluable experience working with prominent companies including Nissan Chemical Industries Limited and Toudai Tlo, Ltd. His work at these institutions has greatly influenced his research direction and has facilitated the development of his patent portfolio.

Collaborations

In his career, Kamon has collaborated with distinguished coworkers such as Takashi Kadowaki and Toshimasa Yamauchi. These partnerships have enriched his innovative process, allowing for the exchange of ideas and expertise in the field of biotechnology and pharmacology.

Conclusion

In summary, Junji Kamon exemplifies the spirit of innovation, particularly in the area of JAK inhibitors. His patents not only reflect his technical expertise but also his commitment to advancing medical science. His contributions will continue to impact the field, showcasing the importance of research and development in creating effective therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…